Asia Tech Wire (May 27) -- AI- powered Chinese pharmaceutical company QuantumPharm Inc. announced on Sunday that it has passed the listing hearing of the Hong Kong stock exchange and will go public on the main board of the exchange.

Founded in 2015, QuantumPharm leverages quantum physics, artificial intelligence and robotic automation to provide research and development solutions and services to the pharmaceutical and materials science industries.

The company has introduced investors such as Google, Tencent, HongShan, SoftBank Vision Fund, PICC Health & Pension Fund, and 5Y Capital through multiple rounds of financing.

As early as May 2021, QuantumPharm considered listing in the U.S., but eventually canceled its U.S. IPO plans and sought a Hong Kong listing instead.